ICAAC 2014: IRIS and Risk of Early Death Among HIV+ People with Tuberculosis
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 23 September 2014 00:00
- Written by Theo Smart
People coinfected with HIV and tuberculosis (TB) who go onto develop immune reconstitution inflammatory syndrome (IRIS) while on antiretroviral therapy (ART) have a pre-ART immunological profile that is easily distinguishable from those who are at risk of early mortality despite being treated for both HIV and TB, according to a presentation at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy this month in Washington, DC.
ICAAC 2014: Attempt to Shorten Standard Tuberculosis Treatment Fails in REMoxTB Trial
- Details
- Category: Tuberculosis (TB)
- Published on Monday, 08 September 2014 00:00
- Written by Theo Smart
Two 4-month treatment regimens containing moxifloxacin were less effective than the standard 6-month regimen for drug-sensitive tuberculosis (TB), even though they produced a more rapid decline in bacterial load, according to results from the REMoxTB trial, which were presented in a poster session at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy this week in Washington, DC, and published simultaneously in the September 7 New England Journal of Medicine.
AIDS 2014: Novel PaMZ Tuberculosis Regimen Could Reduce Treatment Duration
- Details
- Category: Tuberculosis (TB)
- Published on Monday, 21 July 2014 00:00
- Written by Lesley Odendal
A novel tuberculosis (TB) drug regimen could treat drug-sensitive and some forms of drug-resistant TB far more quickly than current standard therapy, according to findings from a Phase 2b trial presented today at the 20th International AIDS Conference (AIDS 2104) in Melbourne, Australia.
TAG Releases 2014 HIV, Hepatitis C, and Tuberculosis Pipeline Report
- Details
- Category: HIV Treatment
- Published on Monday, 21 July 2014 00:00
- Written by HIVandHepatitis.com
The Treatment Action Group (TAG) and HIV i-Base this week released the latest edition of their annual Pipeline Report, covering new therapies and related technologies for HIV, hepatitis C, and tuberculosis (TB), in conjunction with the 20th International AIDS Conference taking place this week in Melbourne, Australia.
WHO Announces Plan to Eliminate Tuberculosis in Low-incidence Countries
- Details
- Category: Tuberculosis (TB)
- Published on Thursday, 10 July 2014 00:00
- Written by WHO
The World Health Organization (WHO) and the European Respiratory Society (ERS) last week introduced a new framework for the elimination of tuberculosis (TB) in more than 30 low-incidence countries, which includes most of Western Europe, the U.S., Canada, and Australia.
Web Design and Development by